-
Sector Analysis
Bio/Pharmaceutical Outsourcing Report, November 2025
The Bio/Pharmaceutical Outsourcing Report is a monthly analysis of news and trends affecting pharmaceutical Contract Manufacturing Organizations (CMOs). It includes in-depth analyses of the latest business conditions, lists new outsourcing contracts, assesses the latest opportunities and threats for manufacturers, and identifies recent mergers, acquisitions, and financing among CMOs. It also updates readers on facility-level news, such as planned site openings and closures, Good Manufacturing Practice (GMP) inspections, and investments in technology and equipment.
-
Thematic Analysis
FDI Trends in the Middle East (2025)
Following a period of significant Foreign Direct Investment (FDI) growth from 2019 to 2023, the inflow of FDI into the Middle East (ME) has slowed down due to risk premiums affecting investor confidence. Capital market reforms, eased equity caps, and limited FDI screening adopted by the likes of Saudi Arabia and the UAE have made material differences to making nations more compatible with global markets. Still, FDI projects opened in the ME region declined by 10.6% YoY in 2024, according...
-
Sector Analysis
Chronic Hepatitis B Therapeutics Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2034
The report provides an in-depth assessment of the CHB therapeutics market including disease overview, epidemiology, disease management, current treatment options, unmet needs and opportunities, R&D strategies, pipeline assessment, current and future players, and market outlook. The hepatitis B virus (HBV) is a member of the Orthohepadnavirus genus, from the Hepadnaviridae family. HBV is transmitted through infected blood and body fluids, most commonly through unprotected sex and contaminated needles. HBV can also be transmitted from mother to child at birth, which...
-
Sector Analysis
Healthcare Financing Reform in Latvia: a Battle for the Bare Minimum
A new draft amendment of Latvia's Healthcare Financing Law was approved recently by the government, that once again shelves proposals to switch from the current general taxation-funded public healthcare model to a health insurance-based system; this is the latest in a long series of postponements to a change in the public healthcare financing model that is thought would allow for an expansion of the funding base and a much needed boost in the funding of the public healthcare system. GlobalData...
-
Sector Analysis
A Closer Look at the HTA Landscape in Oman, Saudi Arabia, and the UAE
Healthcare systems in the Gulf Cooperation Council (GCC)—comprised of Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates (UAE)—are the most developed in the Middle East region. Driven by rapid population growth, the GCC governments have made—and continue to make—significant investments for transformation in the healthcare sector, while simultaneously introducing cost-containment measures to control healthcare spending. As the value of reimbursed health technologies increases, the governments are increasingly becoming more reliant on economic evaluations or health technology assessments...
-
Product Insights
Neurogenic Orthostatic Hypotension (nOH): Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Neurogenic Orthostatic Hypotension (nOH) - Global Clinical Trials Review, 2025" provides an overview of Neurogenic Orthostatic Hypotension (nOH) Clinical trials scenario. This report provides top line data relating to the clinical trials on Neurogenic Orthostatic Hypotension (nOH). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Gouty Arthritis (Gout): Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Gouty Arthritis (Gout) - Global Clinical Trials Review, 2025" provides an overview of Gouty Arthritis (Gout) Clinical trials scenario. This report provides top line data relating to the clinical trials on Gouty Arthritis (Gout). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Dystrophic Epidermolysis Bullosa: Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Dystrophic Epidermolysis Bullosa - Global Clinical Trials Review, 2025" provides an overview of Dystrophic Epidermolysis Bullosa Clinical trials scenario. This report provides top line data relating to the clinical trials on Dystrophic Epidermolysis Bullosa. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Thrombotic Microangiopathy: Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Thrombotic Microangiopathy - Global Clinical Trials Review, 2025" provides an overview of Thrombotic Microangiopathy Clinical trials scenario. This report provides top line data relating to the clinical trials on Thrombotic Microangiopathy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Chronic Pancreatitis: Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Chronic Pancreatitis - Global Clinical Trials Review, 2025" provides an overview of Chronic Pancreatitis Clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Pancreatitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.